...parlayed early clinical data into a €127 million ($154.8 million) series B financing led by HBM Healthcare Investments...
...#), MDX-1106 (Compound #), BMS-936558 (Compound #), nivolumab (Generic), Opdivo (Other) IO102 IO103 Keytruda, pembrolizumab (MK-3475, lambrolizumab) IO Biotech ApS HBM Healthcare Investments University...

...round, joined by Flagship Pioneering and other existing investors plus new institutional investors including Invus Public Equities, HBM Healthcare Investments...
...Greater China. Sequoia China led the round with participation from OrbiMed Advisors, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments...

...Novartis Institutes for BioMedical Research (NIBR).Beyond RA Capital, Werewolf’s new series B investors include Deerfield Management, HBM Healthcare Investments...

...Investments and GT Fund with participation by existing investors CBC Group, Matrix Partners China and HBM Healthcare Investments...

...will review it using the Project Orbis international review framework.Adrenomed raises €22 millionWellington Partners and HBM Healthcare Investments...

...acids into proteins. New investors included Fidelity Management & Research Co., BlackRock, Cormorant Asset Management, HBM Healthcare Investments...

...33.4% stake, according to a regulatory filing. In addition to Farallon, the syndicate also includes Cormorant, HBM Healthcare Investments...
...collaborators: NoneCorporate partners: Arena Pharmaceuticals Inc.Number of employees: 3Funds raised: $56 millionInvestors: Farallon Capital, Cormorant, HBM Healthcare Investments...

...BioCapital and new investors including BVF Partners, HBM Healthcare Investments...

...million in a series A round led by OrbiMed Advisors, with participation by Cormorant Asset Management, HBM Healthcare Investments...

...from founding investor Versant Ventures and existing investor New Enterprise Associates. Additional new investors included HBM Healthcare Investments...